Subsequent Events (Details) - Subsequent Events. $ / shares in Units, $ in Thousands	Oct. 10, 2023 USD ($) Right $ / shares	Oct. 27, 2023 USD ($)
October 2023 Repurchase Program
Subsequent Event [Line Items]
Repurchase of shares of common stock approved | $		$ 200,000
Zynerba Pharmaceuticals, Inc.
Subsequent Event [Line Items]
Cash consideration per Common Stock | $ / shares	$ 1.1059
Number of contingent value right per Common Stock for each share holder | Right	1
Contingent consideration per Common Stock | $ / shares	$ 2.5444
Aggregate consideration paid | $	$ 60,000